AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

RESMED INC Director's Dealing 2023

Nov 17, 2023

30071_dirs_2023-11-16_1577a8ae-c8ee-4019-af42-41b36493935a.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-16

Reporting Person: BLAISE LUCILE (President, Sleep & RC Business)

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	10305	Direct

Footnotes

F1: Ms. Blaise role change is not subject to reporting effective November, 16,2023.